The Discrepant Aortic Valve Area
A 74-year-old man with a history of hypertension and a 3-year history of exertional dyspnea is referred for echocardiography. His blood pressure at the time of the study is 168/92 mmHg. The sonographer measures the following: left ventricular ejection fraction 62%, aortic valve peak velocity 3.9 m/s, mean gradient 38 mmHg, dimensionless index 0.22, and continuity-equation aortic valve area 0.95 cm². The left ventricular outflow tract velocity-time integral is 18 cm and the aortic valve velocity-time integral is 82 cm. The sonographer notes that the patient's heart rate is 88 bpm and that the left ventricular hypertrophy is concentric with a septal thickness of 14 mm.
1. Classify the severity of this patient's aortic stenosis and explain the discordance between the mean gradient and the calculated valve area.
Read the worked answer
The findings are discordant: a mean gradient of 38 mmHg with a peak velocity of 3.9 m/s suggests moderate-to-severe stenosis, while an area of 0.95 cm² falls in the severe range (≤1.0 cm²).
Key reasoning:
- The dimensionless index of 0.22 is consistent with severe stenosis (<0.25), which supports the area calculation rather than the gradient.
- The low flow state explains the low gradient. Although EF is 62%, the stroke volume index is likely reduced (the LVOT VTI of 18 cm is low-normal), producing low-flow, low-gradient severe AS.
- Hypertension (168/92) increases afterload and can further reduce stroke volume and gradient.
- Concentric LVH with a small LV cavity reduces stroke volume despite preserved EF - a classic paradoxical low-flow, low-gradient pattern.
The correct interpretation is low-flow, low-gradient severe AS with preserved EF, pending confirmation of flow state with stroke volume index and consideration of dobutamine stress echocardiography if flow is confirmed low.
2. What confirmatory steps would you recommend before the patient is labeled with severe aortic stenosis, and what are the pitfalls of each?
Read the worked answer
Recommended confirmatory steps:
Calculate stroke volume index (SVi). Low flow is defined as SVi <35 mL/m². This requires accurate LVOT diameter measurement - a common source of error, since LVOT diameter is squared in the continuity equation. A 1 mm error in LVOT diameter changes the area by roughly 10%.
Re-measure the LVOT diameter and VTI at the same level, ideally with multiple measurements and averaging. Pulsed-wave Doppler sample volume should be 3-5 mm proximal to the valve, and the diameter measured in mid-systole in the parasternal long-axis view.
Dobutamine stress echocardiography is indicated when flow is low and EF is reduced; in paradoxical low-flow severe AS with preserved EF, it can help distinguish true severe AS from pseudosevere AS. Look for an increase in stroke volume and whether the gradient rises above 40 mmHg with a valve area that remains ≤1.0 cm².
Consider calcium scoring by CT if the diagnosis remains uncertain - severe aortic valve calcification supports true severe AS.
Pitfalls: Dobutamine may provoke ischemia or arrhythmia; calcium scoring is not universally available; and measurements must be made with careful attention to technique, since the entire classification hinges on the LVOT diameter.
3. How would you counsel the patient and the referring clinician about management implications?
Read the worked answer
Counseling points:
- The patient has symptomatic aortic stenosis (exertional dyspnea) with findings suggesting severe disease by area and dimensionless index. Symptomatic severe AS is a class I indication for aortic valve replacement, but the discordant gradient warrants confirmation before committing to surgery.
- Blood pressure control should be optimized (target <140/90, and lower if tolerated), which may improve the hemodynamic picture and reduce symptoms.
- If confirmatory testing supports severe AS, surgical or transcatheter aortic valve replacement should be discussed with a heart team. The patient's age and comorbidities will influence the choice.
- If testing shows pseudosevere AS, medical management with close surveillance (every 6-12 months) is appropriate.
- The patient should be counseled that symptoms of syncope, angina, or worsening dyspnea warrant urgent evaluation.